There were 479 press releases posted in the last 24 hours and 153,739 in the last 365 days.

DiseaseCast to Carry Ascel Bio's Flu Maps in 4K Video

Toronto, Ontario and New York, NY, April 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Big Data Media Inc. (BDM), a Toronto-based media company and wholly owned subsidiary of Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), and Ascel Bio, a New York–based public health forecasting and consulting company, are collaborating to make high definition 4K video available of key outbreak risk maps displayed at www.diseasecast.com.

Visitors to the site will be able to see videos of risk changing over time for the entire US and sections of the country at high risk. Video categories will include Ascel Bio’s composite flu map, which shows a NowCast of risks of flu activity by zip code, a mosquito diseases risk map, a composite map of water borne diseases and food poisoning risks, and a heart attack risks map.  Video quality will be high definition and suitable for display on 4K televisions.

“This is a significant technical advance and innovation,” says chief bio-meteorologist Mike Smith.  “It took meteorologists decades to pull together images that showed storms progressing across the country.  People depend on good graphics to understand where risks are heading.  Ascel Bio’s new videos are a valuable contribution to efforts to communicate the risk of disease outbreaks.”

“Luminar is pleased to present this improved feature to the public,” said Chris Cook, Chief Executive Officer. “The videos enhance the user experience at DiseaseCast.”

DiseaseCast is a consumer-focused disease risk forecasting site and mobile application. The site is powered by Big Data Media, a subsidiary of Luminar Media Group. DiseaseCast presents America’s only zip code specific forecast for chronic and infectious disease risks, such as influenza. Output from multiple models for risks are displayed. These include human and avian influenza risk, foodborne and waterborne diseases, mosquito diseases, as well as heart attack risks.  The site has unique visualizations that resemble weather forecast maps.  The risk maps are derived from reliable environmental and public health data, and Ascel Bio uses operationally proven and peer reviewed assessment approaches.  Models and approaches were first used by Ascel Bio in clinical settings since 2011.

About DiseaseCast
DiseaseCast is a partnership between Ascel Bio Inc. (Ascel) and Big Data Media (BDM), a subsidiary or Luminar Media Group (Luminar, OTCMKTS: LRGR) to develop DiseaseCast.com, a consumer-focused disease risk forecasting site and mobile application. The site is powered by BDM using Ascel’s proprietary APIs to generate forecasts from various health and meteorological data sources.  DiseaseCast.com is America’s only zip code specific forecast for chronic and infectious disease risks, such as influenza.

About Luminar:  

The Luminar Media Group has extensive knowledge and experience in the media, marketing and entertainment industries.  Our company was started by entrepreneurs that have a vision to identify new tools to communicate with the audience.  Our presence is a natural response to a new way of working in a changing landscape. At Luminar, we embrace the challenge of the constantly evolving business landscape and our determined culture will develop solutions.

About Ascel Bio:

Ascel Bio produces proprietary news and analysis for customers who share an interest in disease outbreaks and recognize the importance of filling gaps in local public health information.  Ascel’s value-added content has been distributed under license to physicians, corporate chief medical officers and business continuity analysts, government crisis managers, quarantine officers, and health officials, and to community groups directly.  Our team delivers insight, promotes awareness, and supports education.

Contact Details: 

Mr. Mike Smith
Chief Bio-Meteorologist
Ascel Bio Inc.
msmith@ascelbio.com
(316) 636-7373

Forward-Looking Statements
This news release contains forward-looking statements about our business, or financial condition and prospects, that reflect our assumptions and beliefs based on information currently available. The Company can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.

Investors should refer to the risk factors disclosure outlined in our periodic reports filed from time-to-time with the Securities and Exchange Commission.

Luminar Media Group Investor Relations
Email: info@luminarinc.com,
Website: http://www.luminarinc.com/

/EIN News/ -- 1532549443607_5b588fc8cf53500004bf2e6c_logo.png

Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.